Pfizer’s Phase 3 clinical trial of XELJANZ in ankylosing spondylitis: A breakthrough in treatment

pharmanewsdaily- November 8, 2020 0

Pfizer has announced the successful completion of a Phase 3 clinical trial for its drug XELJANZ (tofacitinib) in adults with active ankylosing spondylitis (AS), a ... Read More

Amazing Arthritis Prevention Tips & Natural Remedies for Arthritis Revealed!

pharmanewsdaily- March 30, 2018 0

Know about Arthritis – the common bone and joint problem. Find out the different types of Arthritis, Arthritis treatment and the Arthritis natural Remedies. Arthritis ... Read More